title: Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
abstract: Morphine administration elicits pronounced effects on the immune system, including decreases in natural killer (NK) cell activity and lymphocyte mitogenic responsiveness. These immune alterations can become conditioned to environmental stimuli that predict morphine as a result of Pavlovian conditioning processes. Prior work in our laboratory has shown that acute morphine exposure produces dopamine-dependent reductions of NK cell activity that are mediated peripherally by neuropeptide Y Y1 receptors. The present study examined the involvement of dopamine D1 and neuropeptide Y Y1 receptors in the conditioned immunomodulatory effects of morphine. Rats received two conditioning sessions during which an injection of morphine was paired with a distinctive environment which served as the conditioned stimulus (CS). The results show that systemic administration of the D1 antagonist SCH-23390 prior to CS re-exposure prevented the conditioned suppression of splenic NK activity but did not alter conditioned decreases in mitogen-induced lymphocyte proliferation. Furthermore, bilateral microinjections of SCH-23390 directly into the nucleus accumbens shell fully blocked conditioned changes in NK activity. In a subsequent manipulation, subcutaneous injection of the Y1 receptor antagonist BIBP3226 prior to CS re-exposure was also shown to prevent conditioned effects on NK activity. Collectively, these findings provide evidence that the nucleus accumbens shell plays an important role in conditioned immunomodulation and further suggest that the conditioned and unconditioned immunomodulatory effects of opioids involve similar receptor mechanisms.
authors: Department of Psychology, Davie Hall, CB#3270, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3270, USA.
authors: Timothy B
authors: TB
authors: Saurer
authors: Stephanie G
authors: SG
authors: Ijames
authors: Kelly A
authors: KA
authors: Carrigan
authors: Donald T
authors: DT
authors: Lysle
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001552:Benzazepines / Q000008:administration & dosage / Q000494:pharmacology; D003214:Conditioning, Classical; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D007107:Immune System / Q000187:drug effects*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008297:Male; D008845:Microinjections; D009020:Morphine / Q000494:pharmacology*; D015213:Neuroimmunomodulation / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology; D051381:Rats; D011917:Rats, Inbred Lew; D017476:Receptors, Neuropeptide Y / Q000037:antagonists & inhibitors; D013154:Spleen / Q000166:cytology / Q000276:immunology
chemical_list: C092926:BIBP 3226; D001552:Benzazepines; D018492:Dopamine Antagonists; D017476:Receptors, Neuropeptide Y; C097212:neuropeptide Y-Y1 receptor; D009020:Morphine; D001120:Arginine
references: Neuroscience. 2001;108(1):91-102
references: 11738134
references: J Neuroimmunol. 2002 Nov;132(1-2):25-33
references: 12417430
references: Eur J Neurosci. 2003 Sep;18(5):1306-14
references: 12956729
references: J Neuroimmunol. 2003 Aug;141(1-2):20-9
references: 12965250
references: Neuropharmacology. 2004;47 Suppl 1:227-41
references: 15464140
references: Pharmacol Biochem Behav. 1975 Mar-Apr;3(2):185-8
references: 1144478
references: Psychosom Med. 1975 Jul-Aug;37(4):333-40
references: 1162023
references: Life Sci. 1976 May 1;18(9):971-5
references: 1271966
references: Int J Immunopharmacol. 1979;1(2):141-5
references: 551961
references: Science. 1982 Mar 19;215(4539):1534-6
references: 7063864
references: Behav Neurosci. 1983 Aug;97(4):663-6
references: 6615642
references: Science. 1984 Jan 13;223(4632):188-90
references: 6691146
references: J Immunol Methods. 1984 Mar 30;68(1-2):235-49
references: 6200539
references: J Immunol. 1985 Aug;135(2 Suppl):755s-765s
references: 2861231
references: Proc Natl Acad Sci U S A. 1986 Sep;83(18):7114-7
references: 3018757
references: J Neurosci Res. 1987;18(1):37-48
references: 2890771
references: Brain Behav Immun. 1988 Jun;2(2):102-13
references: 3266082
references: Biol Psychol. 1989 Feb;28(1):25-39
references: 2675991
references: Psychopharmacology (Berl). 1990;101(4):472-80
references: 2167492
references: J Pharmacol Exp Ther. 1990 Oct;255(1):101-7
references: 2120421
references: Neuroscience. 1991;41(1):89-125
references: 2057066
references: Brain Behav Immun. 1991 Sep;5(3):308-17
references: 1954405
references: Brain Behav Immun. 1992 Mar;6(1):64-73
references: 1315181
references: J Neuroimmunol. 1992 Jun;38(3):209-19
references: 1351060
references: J Neuroimmunol. 1992 Aug;39(3):219-30
references: 1644897
references: Brain Behav Immun. 1992 Jun;6(2):179-88
references: 1324030
references: J Pharmacol Exp Ther. 1993 Mar;264(3):1179-86
references: 8383741
references: Brain Behav Immun. 1993 Mar;7(1):70-8
references: 8471799
references: J Pharmacol Exp Ther. 1993 Jun;265(3):1071-8
references: 7685383
references: J Pharmacol Exp Ther. 1993 Jun;265(3):1079-87
references: 8389851
references: J Physiol. 1993 Nov;471:209-21
references: 8120804
references: J Neuroimmunol. 1994 Oct;54(1-2):81-6
references: 7929806
references: J Neuroimmunol. 1994 Dec;55(2):135-42
references: 7829663
references: Brain Behav Immun. 1994 Sep;8(3):204-17
references: 7865892
references: J Pharmacol Exp Ther. 1996 May;277(2):633-45
references: 8627540
references: J Pharmacol Exp Ther. 1996 Feb;276(2):626-36
references: 8632330
references: J Neuroimmunol. 1996 Jun;67(1):67-70
references: 8707932
references: Regul Pept. 1996 Aug 27;65(1):71-7
references: 8876038
references: Pharmacol Biochem Behav. 1997 Sep;58(1):275-9
references: 9264103
references: J Neuroimmunol. 1997 Nov;79(2):101-12
references: 9394782
references: Brain Res. 1998 Jun 22;797(1):73-93
references: 9630528
references: J Neuroimmunol. 1998 Aug 1;88(1-2):182-91
references: 9688340
references: Prog Neurobiol. 2004 Dec;74(5):301-20
references: 15582224
references: J Neuroimmunol. 2005 Jun;163(1-2):40-52
references: 15885307
references: J Neuroimmunol. 2006 Apr;173(1-2):3-11
references: 16364456
references: J Neuroimmunol. 2006 Aug;177(1-2):18-26
references: 16766046
references: Psychopharmacology (Berl). 2007 May;191(4):879-89
references: 17211650